MARKET

ALEC

ALEC

Alector
NASDAQ
1.990
+0.180
+9.94%
After Hours: 1.928 -0.062 -3.12% 19:59 10/05 EDT
OPEN
2.725
PREV CLOSE
1.810
HIGH
2.730
LOW
1.960
VOLUME
89.98M
TURNOVER
--
52 WEEK HIGH
3.400
52 WEEK LOW
1.090
MARKET CAP
222.20M
P/E (TTM)
-1.8225
1D
5D
1M
3M
1Y
5Y
1D
Alector surges on licensing agreement with Genentech
Seeking Alpha · 17h ago
Analysts Conflicted on These Healthcare Names: Capricor Therapeutics (CAPR), Alector (ALEC) and Irhythm Technologies (IRTC)
TipRanks · 17h ago
Why is Alector Stock (ALEC) 60% Higher Today?
TipRanks · 18h ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 19h ago
Alector Enters Licensing Agreement With Genentech for Parkinson's Therapy
Dow Jones · 19h ago
Alector Signs Global License Deal With Genentech For AL050
NASDAQ · 20h ago
Alector Licenses AL050 GCase Program to Genentech
TipRanks · 20h ago
Alector enters exclusive AL050 global licensing agreement with Genentech
TipRanks · 20h ago
More
About ALEC
Alector, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. It also develops alector brain carrier (ABC), a proprietary blood-brain barrier platform, which is applied to its next-generation product candidates and research pipeline. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration. Its clinical development portfolio includes latozinemab (AL001) and AL101/GSK4527226, while its preclinical and research pipeline candidates include ADP037-ABC, ADP050-ABC, ADP056, and ADP063-ABC/ADP064-ABC. Its first product candidate, latozinemab, is a human recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of FTD-GRN patients. The AL101/GSK4527226, is a human recombinant monoclonal antibody designed to elevate PGRN levels in the brain.

Webull offers Alector Inc stock information, including NASDAQ: ALEC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALEC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALEC stock methods without spending real money on the virtual paper trading platform.